Time-restricted Feeding as a Dietary Strategy Against Metabolic Disturbances in Humans
- Conditions
- Overweight and Obesity
- Interventions
- Behavioral: Late Time-Restricted FeedingBehavioral: Early Time-Restricted Feeding
- Registration Number
- NCT04351672
- Lead Sponsor
- German Institute of Human Nutrition
- Brief Summary
This human dietary intervention study with a cross-over design aims to compare the effects of two isocaloric diets - early time-restricted feeding (TRF) vs. late TRF - on glycemic control and lipid metabolism in overweight and obese women.
- Detailed Description
The participants are randomly allocated to one of two study groups: In study group (A) participants will begin with the early TRF (e-TRF) intervention. They will consume their habitual food (and the habitual daily amount of food) between 8 am and 4 pm for two weeks. After a washout-phase participants will conduct the late TRF (l-TRF) and consume their habitual food between 1 pm and 9 pm for another two weeks. Study group (B) receives the same interventions in the reversed order. Both dietary regimens will result in 8-hr eating period and 16-hr fasting period during the 24h day.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 31
- BMI 25-35 kg/m²
- prior diagnosis of type 1 or 2 diabetes
- weight changes > 5% within past 3 months
- current shift work or history of shift work
- traveled across more than one time zone one month before the study
- poor quality of sleep (PSQI score>10)
- eating disorders, food intolerance/allergy, severe indigestion
- Pregnant or breastfeeding
- severe internal or psychiatric disorders or other conditions that might influence the outcome of the study
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- CROSSOVER
- Arm && Interventions
Group Intervention Description Late Time-Restricted Feeding Late Time-Restricted Feeding - Early Time-Restricted Feeding Early Time-Restricted Feeding -
- Primary Outcome Measures
Name Time Method Insulin sensitivity 2 weeks Assessed using Matsuda index in oral glucose tolerance test (OGTT)
- Secondary Outcome Measures
Name Time Method Anthropometric parameters: BMI 2 weeks BMI in kg/m\^2
Metabolic hormones and inflammatory markers 2 weeks Levels of hormones related to the glucose metabolism, hormones of appetite regulation, adipokines and inflammatory markers
Blood lipids 2 weeks Total cholesterol, low-density lipoprotein and high-density lipoprotein cholesterol and triglycerides
Anthropometric parameters: fat and lean mass 2 weeks Fat and lean mass in kilograms assessed by bioelectrical impedance analysis
Food intake: macronutrient composition 14 days Macronutrient composition in percentage of energy intake as assessed by food records
Sleep quality and timing 2 weeks (PSQI) and 14 days (ActiGraph, sleep diary) Sleep quality as assessed by the Pittsburgh Sleep Quality Index (PSQI score, which ranges from 0-21, where higher values correspond to worse sleep quality) and by the ActiGraph device; sleep timing (sleep onset and offset) as monitored using a sleep diary
Glucose tolerance, fasting glucose, and overall daily glycemic variation 2 weeks (OGTT) and 14 days (CGM) Assessed by glucose area under the curve in OGTT and using a continuous glucose monitoring (CGM)
Oxidative stress markers 2 weeks Malondialdehyde, 3-nitrotyrosine, and protein carbonyls
Food intake: eating times 14 days Eating times in hours and minutes as assessed by food records
Food intake: calorie intake 14 days Calorie intake in kilocalories as assessed by food records
Physical activity 14 days 24-h physical activity as monitored by an ActiGraph device
Anthropometric parameters: waist circumference 2 weeks Waist circumference in centimeters
Blood pressure 2 weeks Systolic and diastolic blood pressure
Liver enzymes 2 weeks γ-glutamyltransferase (GGT), aspartate aminotransferase (ALT), and alanine aminotransferase (AST)
Anthropometric parameters: body weight 2 weeks Body weight in kilograms
Satiety and hunger scores 2 weeks Assessed using Visual Analog Scales (VAS with a scale of 1-100, where higher values correspond to stronger satiety/hunger)
Expression of metabolic genes in adipose tissue 2 weeks RNA-Seq analysis of subcutaneous adipose tissue samples
Social and economic decision behaviour 2 weeks Assessed by computer tests together with the Barratt Impulsiveness Scale short version (BIS-15 with a score between 15 and 60, where higher values correspond to higher impulsiveness) and the UCLA Loneliness Scale (with a score between 20 and 100, where higher values correspond to higher subjectively perceived loneliness)
Trial Locations
- Locations (1)
German Institute of Human Nutrition Potsdam-Rehbruecke
🇩🇪Nuthetal, Germany